Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
Med Clin (Engl Ed)
.
2022 Nov 11;159(9):e61.
doi: 10.1016/j.medcle.2022.05.022.
Epub 2022 Nov 3.
Authors
Chia Siang Kow
1
,
Dinesh Sangarran Ramachandram
2
,
Syed Shahzad Hasan
3
4
Affiliations
1
School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
2
School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
3
School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom.
4
School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.
PMID:
36345468
PMCID:
PMC9631200
DOI:
10.1016/j.medcle.2022.05.022
No abstract available